| English Name | Research Code | Highest Development Stage | Company | Indication | Clinical Trial |
|---|---|---|---|---|---|
| 9MW3811 | 9MW3811 | Phase 2 Clinical | Mabwell (Shanghai) Bioscience Co Ltd | Cicatrix; Fibrosis; Idiopathic Pulmonary Fibrosis; Neoplasms; Pulmonary Fibrosis; Solid tumours | Details |
| BI-765423 | BI-765423; BI765423 | Phase 2 Clinical | Boehringer Ingelheim Ltd | Idiopathic Pulmonary Fibrosis | Details |
| HB-0056 | HB-0056; HB0056 | Phase 1 Clinical | Shanghai Huaota Biopharmaceutical Co Ltd, Zhejiang Huahai Pharmaceutical Co Ltd | Asthma; Dermatitis, Atopic; Idiopathic Pulmonary Fibrosis; Pulmonary Disease, Chronic Obstructive | Details |
| LASN-03 | Lassen Therapeutics | Details |
| English Name | Research Code | Highest Development Stage | Company | First Brand Name | First Approved Country | First Indication | First Approved Company | First Approved Date | Indication | Clinical Trial |
|---|---|---|---|---|---|---|---|---|---|---|
| Recombinant human interleukin-11 (Hangzhou Jiuyuan Gene Engineering Co Ltd ) | Approved | Hangzhou Jiuyuan Gene Biomedical Co Ltd | Thrombocytopenia | Details |